These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 7998769

  • 21. Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy.
    Tackenberg B, Lünemann JD, Steinbrecher A, Rothenfusser-Korber E, Sailer M, Brück W, Schock S, Zschenderlein R, Zipp F, Sommer N.
    Neurology; 2007 May 08; 68(19):1622-9. PubMed ID: 17485651
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Serum demyelinating activity and Guillain-Barre syndrome: favorable effect of plasma exchange].
    Metral S, Raphael JC, Hort-Legrand CI, Elkharrat D.
    Rev Neurol (Paris); 1989 May 08; 145(4):312-9. PubMed ID: 2660223
    [Abstract] [Full Text] [Related]

  • 24. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg.
    Caro XJ, Winter EF, Dumas AJ.
    Rheumatology (Oxford); 2008 Feb 08; 47(2):208-11. PubMed ID: 18208823
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study.
    Hahn AF, Bolton CF, Zochodne D, Feasby TE.
    Brain; 1996 Aug 08; 119 ( Pt 4)():1067-77. PubMed ID: 8813271
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Chronic inflammatory demyelinating polyneuropathy in a patient with hyperIgEaemia.
    Kimura A, Yoshino H, Yuasa T.
    J Neurol Sci; 2005 Apr 15; 231(1-2):89-93. PubMed ID: 15792827
    [Abstract] [Full Text] [Related]

  • 34. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.
    Achiron A, Kishner I, Sarova-Pinhas I, Raz H, Faibel M, Stern Y, Lavie M, Gurevich M, Dolev M, Magalashvili D, Barak Y.
    Arch Neurol; 2004 Oct 15; 61(10):1515-20. PubMed ID: 15477504
    [Abstract] [Full Text] [Related]

  • 35. [Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange].
    Kamei T, Nakagawa H, Uchiyama F, Fukuyama J.
    Rinsho Shinkeigaku; 1993 Jun 15; 33(6):660-2. PubMed ID: 8403689
    [Abstract] [Full Text] [Related]

  • 36. Immune mediated neuropathies--an update on therapeutic strategies.
    Czaplinski A, Steck AJ.
    J Neurol; 2004 Feb 15; 251(2):127-37. PubMed ID: 14991345
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.